SYNT vs. VCT, ELM, SCPA, ESNT, TET, ZTF, IOF, WCH, ITX, and DCTA
Should you be buying Synthomer stock or one of its competitors? The main competitors of Synthomer include Victrex (VCT), Elementis (ELM), Scapa Group (SCPA), Essentra (ESNT), Treatt (TET), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), and Directa Plus (DCTA). These companies are all part of the "specialty chemicals" industry.
Synthomer vs.
Victrex (LON:VCT) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings, institutional ownership and community ranking.
Victrex currently has a consensus price target of GBX 1,425, indicating a potential upside of 34.94%. Synthomer has a consensus price target of GBX 288.33, indicating a potential upside of 86.74%. Given Synthomer's stronger consensus rating and higher possible upside, analysts plainly believe Synthomer is more favorable than Victrex.
97.1% of Victrex shares are owned by institutional investors. Comparatively, 43.8% of Synthomer shares are owned by institutional investors. 1.6% of Victrex shares are owned by insiders. Comparatively, 28.0% of Synthomer shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Victrex has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, Synthomer has a beta of 1.79, meaning that its share price is 79% more volatile than the S&P 500.
Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 5.7%. Synthomer pays an annual dividend of GBX 25 per share and has a dividend yield of 16.2%. Victrex pays out 17,142.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Synthomer pays out -4,098.4% of its earnings in the form of a dividend. Synthomer is clearly the better dividend stock, given its higher yield and lower payout ratio.
Victrex has a net margin of 10.81% compared to Synthomer's net margin of -4.33%. Victrex's return on equity of 6.36% beat Synthomer's return on equity.
In the previous week, Victrex had 4 more articles in the media than Synthomer. MarketBeat recorded 4 mentions for Victrex and 0 mentions for Synthomer. Victrex's average media sentiment score of 1.47 beat Synthomer's score of 0.00 indicating that Victrex is being referred to more favorably in the media.
Victrex has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Victrex, indicating that it is currently the more affordable of the two stocks.
Synthomer received 219 more outperform votes than Victrex when rated by MarketBeat users. Likewise, 68.49% of users gave Synthomer an outperform vote while only 63.61% of users gave Victrex an outperform vote.
Summary
Victrex and Synthomer tied by winning 10 of the 20 factors compared between the two stocks.
Get Synthomer News Delivered to You Automatically
Sign up to receive the latest news and ratings for SYNT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Synthomer Competitors List
Related Companies and Tools
This page (LON:SYNT) was last updated on 12/22/2024 by MarketBeat.com Staff